「for」の検索結果
125件：16～20件目を表示
-
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
non-clinical ocular instillation toxicity studies of SJP-0132, a TRPV1 antagonist, a novel eye drop for dry eye disease Hideya Yonekura, Kotaro Yamada, Gen Suzuki, Yu Haranosono, Yoshinori Yamagiwa, I...
https://www.senju.co.jp/rd/society/ -
Supplement business | Business Activities | About Senju | SENJU Pharmaceutical
Wellness items that promote health every day to contribute to the health of all people. Senju Pharmaceutical, as a pioneer of ophthalmic drugs, has long engaged in developing prescription and OTC drug
https://www.senju.co.jp/english/about/business/ec.html -
学会发表 | 研究与开发 | 千寿制药株式会社
non-clinical ocular instillation toxicity studies of SJP-0132, a TRPV1 antagonist, a novel eye drop for dry eye disease Hideya Yonekura, Kotaro Yamada, Gen Suzuki, Yu Haranosono, Yoshinori Yamagiwa, I...
http://www.senju.co.jp/chinese/rd/society/ -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
heng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106-16. #1...
https://www.senju.co.jp/rd/policy/ -
临床试验信息 | 研究与开发 | 千寿制药株式会社
Dry Eye Disease 1/2 SJP-0132 United States Completed NCT04139122 Disclaimer This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as...
http://www.senju.co.jp/chinese/rd/trial.html